Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: Correlation with induction of increased levels of intracellular interkukin-2 in peripheral blood lymphocytes

This publication has 22 references indexed in Scilit:

• Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
  Science, 1996
• The Tumor Enhancement Phenomenon: Reinterpretation From a Th1/Th2 Perspective
  JNCI Journal of the National Cancer Institute, 1996
• Tuberculosis and cancer: parallels in host responses and therapeutic approaches?
  The Lancet, 1995
• Immunoregulatory effects of CD4+ T helper subsets in human melanoma
  Surgery, 1995
• Approaches to Augmenting the IgG Antibody Response to Melanoma Ganglioside Vaccines
  Annals of the New York Academy of Sciences, 1993
• Local expression of antiinflammatory cytokines in cancer.
  Journal of Clinical Investigation, 1993
• Tumor Rejection After Direct Costimulation of CD8 ⁺ T Cells by B7-Transfected Melanoma Cells
  Science, 1993
• Decreased interleukin-2 β-chain receptor expression by interleukin-4 on LGL: influence on the IL-2 induced cytotoxicity and proliferation
  Cancer Letters, 1992
• Regulation of Immune Responses by T Cells with Different Cytokine Secretion Phenotypes: Role of a New Cytokine, Cytokine Synthesis Inhibitory Factor (IL10)
  International Archives of Allergy and Immunology, 1991
• BCG lmmunotherapy of Malignant Melanoma
  Annals of Surgery, 1974